The association between the severity of diabetic retinopathy and cognitive impairment: a cross-sectional study

Int Ophthalmol. 2024 Feb 8;44(1):30. doi: 10.1007/s10792-024-03022-y.

Abstract

Purpose: To assess the correlation among cognitive impairment (CI) and the degree of diabetic retinopathy (DR).

Methods: The current analytic cross-sectional study has been carried out on two hundred ten individuals having diabetes mellitus type 2. Individuals were split into 7 groups in order of severity of DR in the worse eye with 30 cases in each group. Cognition function has been determined utilizing mini-mental state examination (MMSE) and montreal cognitive assessment (MoCA) tests.

Results: Comparing the severity of CI using both MMSE and MoCA tests, statistically substantial differences have been discovered among individuals without DR, those having non-proliferative diabetic retinopathy (NPDR), and proliferative diabetic retinopathy (PDR) (p < 0.001). The greatest percentage of severe and moderate CI was seen in the PDR group. Regarding the severity of CI, there has been a statistically substantial difference among NPDR and PDR groups, as well as among no-DR and PDR groups (p < 0.001). Moreover, the severity of CI in the MMSE and MoCA tests had a negative connection with the grades of DR (r = - 0.522, P < 0.001 and r = - 0.540, P < 0.001, respectively).

Conclusion: We discovered a negative connection between the grades of DR and the severity of CI that persisted as a significant finding, showing that patients with more severe DR tended to have higher levels of CI. These results might offer retinal examination or retinal photography as a promising strategy for mass screening of CI in diabetic patients, especially if it is combined with artificial intelligence and telemedicine.

Keywords: Cognitive dysfunction; Diabetic retinopathy; Mental status and dementia tests; Mini-mental state examination; Montreal cognitive assessment test.

MeSH terms

  • Artificial Intelligence
  • Cognitive Dysfunction* / diagnosis
  • Cognitive Dysfunction* / etiology
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetic Retinopathy* / complications
  • Diabetic Retinopathy* / diagnosis
  • Humans